10 20 30 40 50 60 70 80 2O5D - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER VIRAL PROTEIN 05-DEC-06 2O5D
TITLE THIAZOLONE-ACYLSULFONAMIDES AS NOVEL HCV NS5B POLYMERASE TITLE 2 ALLOSTERIC INHIBITORS: CONVERGENCE OF STRUCTURE-BASED DRUG TITLE 3 DESIGN AND X-RAY CRYSTALLOGRAPHIC STUDY
COMPND MOL_ID: 1; COMPND 2 MOLECULE: HCV; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: HCV NS5B; COMPND 5 EC: 2.7.7.48; COMPND 6 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HEPATITIS C VIRUS; SOURCE 3 ORGANISM_TAXID: 11103; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS HCV, NS5B, VIRAL RNA-DIRECTED RNA POLYMERASE, RDRP, KEYWDS 2 ALLOSTERIC INHIBITOR, HCV INHIBITOR COMPLEX, STRUCTURE- KEYWDS 3 BASED DRUG DESIGN, VIRAL PROTEIN
EXPDTA X-RAY DIFFRACTION
AUTHOR N.YAO
REVDAT 3 24-FEB-09 2O5D 1 VERSN REVDAT 2 27-MAR-07 2O5D 1 JRNL REVDAT 1 20-FEB-07 2O5D 0
JRNL AUTH S.YAN,T.APPLEBY,G.LARSON,J.Z.WU,R.K.HAMATAKE, JRNL AUTH 2 Z.HONG,N.YAO JRNL TITL THIAZOLONE-ACYLSULFONAMIDES AS NOVEL HCV NS5B JRNL TITL 2 POLYMERASE ALLOSTERIC INHIBITORS: CONVERGENCE OF JRNL TITL 3 STRUCTURE-BASED DRUG DESIGN AND X-RAY JRNL TITL 4 CRYSTALLOGRAPHIC STUDY. JRNL REF BIOORG.MED.CHEM.LETT. V. 17 1991 2007 JRNL REFN ISSN 0960-894X JRNL PMID 17276060 JRNL DOI 10.1016/J.BMCL.2007.01.024
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 99.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 9.9 REMARK 3 NUMBER OF REFLECTIONS : 57186 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.250 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 5820 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8721 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 76 REMARK 3 SOLVENT ATOMS : 429 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 2O5D COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-DEC-06. REMARK 100 THE RCSB ID CODE IS RCSB040707.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-OCT-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC BLUE MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 58370 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 99.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 12.900 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : 0.26900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.62 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 4000, 5 MM DTT, 0.5M MES, REMARK 280 1.0 M NACL, MICRO BATCH,, PH 5.0, EVAPORATION, TEMPERATURE 295K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 42.71000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 63.21550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 52.68450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 63.21550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 42.71000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 52.68450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A -5 REMARK 465 SER A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 HIS A -1 REMARK 465 HIS A 0 REMARK 465 PRO A 149 REMARK 465 GLU A 150 REMARK 465 LYS A 151 REMARK 465 GLY A 152 REMARK 465 GLY A 153 REMARK 465 SER A 565 REMARK 465 ARG A 566 REMARK 465 ALA A 567 REMARK 465 ARG A 568 REMARK 465 PRO A 569 REMARK 465 ARG A 570 REMARK 465 ALA B -5 REMARK 465 SER B -4 REMARK 465 HIS B -3 REMARK 465 HIS B -2 REMARK 465 HIS B -1 REMARK 465 HIS B 0 REMARK 465 PRO B 149 REMARK 465 GLU B 150 REMARK 465 LYS B 151 REMARK 465 GLY B 152 REMARK 465 GLY B 153 REMARK 465 ALA B 567 REMARK 465 ARG B 568 REMARK 465 PRO B 569 REMARK 465 ARG B 570
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 15 -171.81 -179.59 REMARK 500 LEU A 260 -54.65 -127.44 REMARK 500 SER A 347 52.00 72.27 REMARK 500 ALA A 348 56.32 -152.64 REMARK 500 ILE A 424 -64.84 -101.70 REMARK 500 SER A 473 17.64 -141.35 REMARK 500 LEU A 534 -162.07 -104.91 REMARK 500 LEU A 536 97.53 61.91 REMARK 500 TYR A 555 31.31 -140.32 REMARK 500 PHE B 101 40.41 -108.60 REMARK 500 LEU B 260 -56.00 -125.74 REMARK 500 SER B 347 52.88 73.43 REMARK 500 ALA B 348 57.14 -150.76 REMARK 500 ILE B 424 -65.90 -101.05 REMARK 500 SER B 473 18.46 -141.51 REMARK 500 LEU B 536 90.96 66.57 REMARK 500 REMARK 500 REMARK: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE VR1 A 600 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE VR1 B 600
DBREF 2O5D A 3 570 UNP P26663 POLG_HCVBK 2422 2989 DBREF 2O5D B 3 570 UNP P26663 POLG_HCVBK 2422 2989
SEQRES 1 A 576 ALA SER HIS HIS HIS HIS HIS HIS SER TYR THR TRP THR SEQRES 2 A 576 GLY ALA LEU ILE THR PRO CYS ALA ALA GLU GLU SER LYS SEQRES 3 A 576 LEU PRO ILE ASN ALA LEU SER ASN SER LEU LEU ARG HIS SEQRES 4 A 576 HIS ASN MET VAL TYR ALA THR THR SER ARG SER ALA GLY SEQRES 5 A 576 LEU ARG GLN LYS LYS VAL THR PHE ASP ARG LEU GLN VAL SEQRES 6 A 576 LEU ASP ASP HIS TYR ARG ASP VAL LEU LYS GLU MET LYS SEQRES 7 A 576 ALA LYS ALA SER THR VAL LYS ALA LYS LEU LEU SER VAL SEQRES 8 A 576 GLU GLU ALA CYS LYS LEU THR PRO PRO HIS SER ALA LYS SEQRES 9 A 576 SER LYS PHE GLY TYR GLY ALA LYS ASP VAL ARG ASN LEU SEQRES 10 A 576 SER SER LYS ALA VAL ASN HIS ILE HIS SER VAL TRP LYS SEQRES 11 A 576 ASP LEU LEU GLU ASP THR VAL THR PRO ILE ASP THR THR SEQRES 12 A 576 ILE MET ALA LYS ASN GLU VAL PHE CYS VAL GLN PRO GLU SEQRES 13 A 576 LYS GLY GLY ARG LYS PRO ALA ARG LEU ILE VAL PHE PRO SEQRES 14 A 576 ASP LEU GLY VAL ARG VAL CYS GLU LYS MET ALA LEU TYR SEQRES 15 A 576 ASP VAL VAL SER THR LEU PRO GLN VAL VAL MET GLY SER SEQRES 16 A 576 SER TYR GLY PHE GLN TYR SER PRO GLY GLN ARG VAL GLU SEQRES 17 A 576 PHE LEU VAL ASN THR TRP LYS SER LYS LYS ASN PRO MET SEQRES 18 A 576 GLY PHE SER TYR ASP THR ARG CYS PHE ASP SER THR VAL SEQRES 19 A 576 THR GLU ASN ASP ILE ARG VAL GLU GLU SER ILE TYR GLN SEQRES 20 A 576 CYS CYS ASP LEU ALA PRO GLU ALA ARG GLN ALA ILE LYS SEQRES 21 A 576 SER LEU THR GLU ARG LEU TYR ILE GLY GLY PRO LEU THR SEQRES 22 A 576 ASN SER LYS GLY GLN ASN CYS GLY TYR ARG ARG CYS ARG SEQRES 23 A 576 ALA SER GLY VAL LEU THR THR SER CYS GLY ASN THR LEU SEQRES 24 A 576 THR CYS TYR LEU LYS ALA SER ALA ALA CYS ARG ALA ALA SEQRES 25 A 576 LYS LEU GLN ASP CYS THR MET LEU VAL ASN GLY ASP ASP SEQRES 26 A 576 LEU VAL VAL ILE CYS GLU SER ALA GLY VAL GLN GLU ASP SEQRES 27 A 576 ALA ALA SER LEU ARG ALA PHE THR GLU ALA MET THR ARG SEQRES 28 A 576 TYR SER ALA PRO PRO GLY ASP PRO PRO GLN PRO GLU TYR SEQRES 29 A 576 ASP LEU GLU LEU ILE THR SER CYS SER SER ASN VAL SER SEQRES 30 A 576 VAL ALA HIS ASP ALA SER GLY LYS ARG VAL TYR TYR LEU SEQRES 31 A 576 THR ARG ASP PRO THR THR PRO LEU ALA ARG ALA ALA TRP SEQRES 32 A 576 GLU THR ALA ARG HIS THR PRO VAL ASN SER TRP LEU GLY SEQRES 33 A 576 ASN ILE ILE MET TYR ALA PRO THR LEU TRP ALA ARG MET SEQRES 34 A 576 ILE LEU MET THR HIS PHE PHE SER ILE LEU LEU ALA GLN SEQRES 35 A 576 GLU GLN LEU GLU LYS ALA LEU ASP CYS GLN ILE TYR GLY SEQRES 36 A 576 ALA CYS TYR SER ILE GLU PRO LEU ASP LEU PRO GLN ILE SEQRES 37 A 576 ILE GLU ARG LEU HIS GLY LEU SER ALA PHE SER LEU HIS SEQRES 38 A 576 SER TYR SER PRO GLY GLU ILE ASN ARG VAL ALA SER CYS SEQRES 39 A 576 LEU ARG LYS LEU GLY VAL PRO PRO LEU ARG VAL TRP ARG SEQRES 40 A 576 HIS ARG ALA ARG SER VAL ARG ALA ARG LEU LEU SER GLN SEQRES 41 A 576 GLY GLY ARG ALA ALA THR CYS GLY LYS TYR LEU PHE ASN SEQRES 42 A 576 TRP ALA VAL LYS THR LYS LEU LYS LEU THR PRO ILE PRO SEQRES 43 A 576 ALA ALA SER GLN LEU ASP LEU SER GLY TRP PHE VAL ALA SEQRES 44 A 576 GLY TYR SER GLY GLY ASP ILE TYR HIS SER LEU SER ARG SEQRES 45 A 576 ALA ARG PRO ARG SEQRES 1 B 576 ALA SER HIS HIS HIS HIS HIS HIS SER TYR THR TRP THR SEQRES 2 B 576 GLY ALA LEU ILE THR PRO CYS ALA ALA GLU GLU SER LYS SEQRES 3 B 576 LEU PRO ILE ASN ALA LEU SER ASN SER LEU LEU ARG HIS SEQRES 4 B 576 HIS ASN MET VAL TYR ALA THR THR SER ARG SER ALA GLY SEQRES 5 B 576 LEU ARG GLN LYS LYS VAL THR PHE ASP ARG LEU GLN VAL SEQRES 6 B 576 LEU ASP ASP HIS TYR ARG ASP VAL LEU LYS GLU MET LYS SEQRES 7 B 576 ALA LYS ALA SER THR VAL LYS ALA LYS LEU LEU SER VAL SEQRES 8 B 576 GLU GLU ALA CYS LYS LEU THR PRO PRO HIS SER ALA LYS SEQRES 9 B 576 SER LYS PHE GLY TYR GLY ALA LYS ASP VAL ARG ASN LEU SEQRES 10 B 576 SER SER LYS ALA VAL ASN HIS ILE HIS SER VAL TRP LYS SEQRES 11 B 576 ASP LEU LEU GLU ASP THR VAL THR PRO ILE ASP THR THR SEQRES 12 B 576 ILE MET ALA LYS ASN GLU VAL PHE CYS VAL GLN PRO GLU SEQRES 13 B 576 LYS GLY GLY ARG LYS PRO ALA ARG LEU ILE VAL PHE PRO SEQRES 14 B 576 ASP LEU GLY VAL ARG VAL CYS GLU LYS MET ALA LEU TYR SEQRES 15 B 576 ASP VAL VAL SER THR LEU PRO GLN VAL VAL MET GLY SER SEQRES 16 B 576 SER TYR GLY PHE GLN TYR SER PRO GLY GLN ARG VAL GLU SEQRES 17 B 576 PHE LEU VAL ASN THR TRP LYS SER LYS LYS ASN PRO MET SEQRES 18 B 576 GLY PHE SER TYR ASP THR ARG CYS PHE ASP SER THR VAL SEQRES 19 B 576 THR GLU ASN ASP ILE ARG VAL GLU GLU SER ILE TYR GLN SEQRES 20 B 576 CYS CYS ASP LEU ALA PRO GLU ALA ARG GLN ALA ILE LYS SEQRES 21 B 576 SER LEU THR GLU ARG LEU TYR ILE GLY GLY PRO LEU THR SEQRES 22 B 576 ASN SER LYS GLY GLN ASN CYS GLY TYR ARG ARG CYS ARG SEQRES 23 B 576 ALA SER GLY VAL LEU THR THR SER CYS GLY ASN THR LEU SEQRES 24 B 576 THR CYS TYR LEU LYS ALA SER ALA ALA CYS ARG ALA ALA SEQRES 25 B 576 LYS LEU GLN ASP CYS THR MET LEU VAL ASN GLY ASP ASP SEQRES 26 B 576 LEU VAL VAL ILE CYS GLU SER ALA GLY VAL GLN GLU ASP SEQRES 27 B 576 ALA ALA SER LEU ARG ALA PHE THR GLU ALA MET THR ARG SEQRES 28 B 576 TYR SER ALA PRO PRO GLY ASP PRO PRO GLN PRO GLU TYR SEQRES 29 B 576 ASP LEU GLU LEU ILE THR SER CYS SER SER ASN VAL SER SEQRES 30 B 576 VAL ALA HIS ASP ALA SER GLY LYS ARG VAL TYR TYR LEU SEQRES 31 B 576 THR ARG ASP PRO THR THR PRO LEU ALA ARG ALA ALA TRP SEQRES 32 B 576 GLU THR ALA ARG HIS THR PRO VAL ASN SER TRP LEU GLY SEQRES 33 B 576 ASN ILE ILE MET TYR ALA PRO THR LEU TRP ALA ARG MET SEQRES 34 B 576 ILE LEU MET THR HIS PHE PHE SER ILE LEU LEU ALA GLN SEQRES 35 B 576 GLU GLN LEU GLU LYS ALA LEU ASP CYS GLN ILE TYR GLY SEQRES 36 B 576 ALA CYS TYR SER ILE GLU PRO LEU ASP LEU PRO GLN ILE SEQRES 37 B 576 ILE GLU ARG LEU HIS GLY LEU SER ALA PHE SER LEU HIS SEQRES 38 B 576 SER TYR SER PRO GLY GLU ILE ASN ARG VAL ALA SER CYS SEQRES 39 B 576 LEU ARG LYS LEU GLY VAL PRO PRO LEU ARG VAL TRP ARG SEQRES 40 B 576 HIS ARG ALA ARG SER VAL ARG ALA ARG LEU LEU SER GLN SEQRES 41 B 576 GLY GLY ARG ALA ALA THR CYS GLY LYS TYR LEU PHE ASN SEQRES 42 B 576 TRP ALA VAL LYS THR LYS LEU LYS LEU THR PRO ILE PRO SEQRES 43 B 576 ALA ALA SER GLN LEU ASP LEU SER GLY TRP PHE VAL ALA SEQRES 44 B 576 GLY TYR SER GLY GLY ASP ILE TYR HIS SER LEU SER ARG SEQRES 45 B 576 ALA ARG PRO ARG
HET VR1 A 600 38 HET VR1 B 600 38
HETNAM VR1 (2S)-2-({(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-4-OXO-4, HETNAM 2 VR1 5-DIHYDRO-1,3-THIAZOL-2-YL}AMINO)-2-(4-FLUOROPHENYL)- HETNAM 3 VR1 N-[(4-NITROPHENYL)SULFONYL]ACETAMIDE
FORMUL 3 VR1 2(C24 H19 F N4 O7 S2) FORMUL 5 HOH *429(H2 O)
HELIX 1 1 LEU A 26 LEU A 31 1 6 HELIX 2 2 HIS A 33 ASN A 35 5 3 HELIX 3 3 THR A 41 ARG A 43 5 3 HELIX 4 4 SER A 44 THR A 53 1 10 HELIX 5 5 ASP A 61 SER A 76 1 16 HELIX 6 6 SER A 84 LEU A 91 1 8 HELIX 7 7 GLY A 104 ASN A 110 1 7 HELIX 8 8 SER A 112 ASP A 129 1 18 HELIX 9 9 ASP A 164 GLY A 188 1 25 HELIX 10 10 SER A 189 TYR A 195 5 7 HELIX 11 11 SER A 196 LYS A 211 1 16 HELIX 12 12 CYS A 223 VAL A 228 1 6 HELIX 13 13 THR A 229 GLN A 241 1 13 HELIX 14 14 ALA A 246 LEU A 260 1 15 HELIX 15 15 THR A 286 ALA A 306 1 21 HELIX 16 16 GLY A 328 TYR A 346 1 19 HELIX 17 17 ASP A 359 ILE A 363 5 5 HELIX 18 18 PRO A 388 ARG A 401 1 14 HELIX 19 19 ASN A 406 ALA A 416 1 11 HELIX 20 20 THR A 418 ILE A 424 1 7 HELIX 21 21 ILE A 424 GLN A 436 1 13 HELIX 22 22 GLU A 455 LEU A 457 5 3 HELIX 23 23 ASP A 458 GLY A 468 1 11 HELIX 24 24 LEU A 469 SER A 473 5 5 HELIX 25 25 SER A 478 GLY A 493 1 16 HELIX 26 26 PRO A 496 GLY A 515 1 20 HELIX 27 27 GLY A 515 PHE A 526 1 12 HELIX 28 28 ILE A 539 SER A 543 5 5 HELIX 29 29 LEU A 547 PHE A 551 5 5 HELIX 30 30 LEU B 26 LEU B 31 1 6 HELIX 31 31 HIS B 33 ASN B 35 5 3 HELIX 32 32 THR B 41 ARG B 43 5 3 HELIX 33 33 SER B 44 VAL B 52 1 9 HELIX 34 34 ASP B 61 SER B 76 1 16 HELIX 35 35 SER B 84 LEU B 91 1 8 HELIX 36 36 GLY B 104 ASN B 110 1 7 HELIX 37 37 SER B 112 ASP B 129 1 18 HELIX 38 38 ASP B 164 GLY B 188 1 25 HELIX 39 39 SER B 189 TYR B 195 5 7 HELIX 40 40 SER B 196 LYS B 211 1 16 HELIX 41 41 CYS B 223 VAL B 228 1 6 HELIX 42 42 THR B 229 GLN B 241 1 13 HELIX 43 43 ALA B 246 LEU B 260 1 15 HELIX 44 44 THR B 286 ALA B 306 1 21 HELIX 45 45 GLY B 328 TYR B 346 1 19 HELIX 46 46 ASP B 359 ILE B 363 5 5 HELIX 47 47 PRO B 388 ARG B 401 1 14 HELIX 48 48 ASN B 406 ALA B 416 1 11 HELIX 49 49 THR B 418 ILE B 424 1 7 HELIX 50 50 ILE B 424 GLU B 437 1 14 HELIX 51 51 GLU B 455 LEU B 457 5 3 HELIX 52 52 ASP B 458 GLY B 468 1 11 HELIX 53 53 LEU B 469 SER B 473 5 5 HELIX 54 54 SER B 478 GLY B 493 1 16 HELIX 55 55 PRO B 496 GLY B 515 1 20 HELIX 56 56 GLY B 515 PHE B 526 1 12 HELIX 57 57 ASN B 527 VAL B 530 5 4 HELIX 58 58 ILE B 539 GLN B 544 5 6
SHEET 1 A 5 TYR A 4 TRP A 6 0 SHEET 2 A 5 ASN A 273 ARG A 277 -1 O TYR A 276 N THR A 5 SHEET 3 A 5 GLY A 264 THR A 267 -1 N LEU A 266 O CYS A 274 SHEET 4 A 5 THR A 136 ALA A 140 1 N THR A 136 O THR A 267 SHEET 5 A 5 LEU A 159 PHE A 162 -1 O ILE A 160 N MET A 139 SHEET 1 B 2 VAL A 37 ALA A 39 0 SHEET 2 B 2 VAL A 144 CYS A 146 -1 O PHE A 145 N TYR A 38 SHEET 1 C 3 PRO A 214 TYR A 219 0 SHEET 2 C 3 ASP A 319 GLU A 325 -1 O CYS A 324 N MET A 215 SHEET 3 C 3 GLN A 309 ASN A 316 -1 N THR A 312 O ILE A 323 SHEET 1 D 2 SER A 368 HIS A 374 0 SHEET 2 D 2 ARG A 380 ARG A 386 -1 O VAL A 381 N ALA A 373 SHEET 1 E 3 LEU A 443 ILE A 447 0 SHEET 2 E 3 ALA A 450 ILE A 454 -1 O ILE A 454 N LEU A 443 SHEET 3 E 3 TYR A 561 SER A 563 1 O HIS A 562 N CYS A 451 SHEET 1 F 5 TYR B 4 TRP B 6 0 SHEET 2 F 5 ASN B 273 ARG B 277 -1 O TYR B 276 N THR B 5 SHEET 3 F 5 GLY B 264 THR B 267 -1 N LEU B 266 O CYS B 274 SHEET 4 F 5 THR B 136 ALA B 140 1 N ILE B 138 O THR B 267 SHEET 5 F 5 LEU B 159 PHE B 162 -1 O ILE B 160 N MET B 139 SHEET 1 G 2 VAL B 37 ALA B 39 0 SHEET 2 G 2 VAL B 144 CYS B 146 -1 O PHE B 145 N TYR B 38 SHEET 1 H 3 PRO B 214 ASP B 220 0 SHEET 2 H 3 ASP B 319 GLU B 325 -1 O VAL B 322 N PHE B 217 SHEET 3 H 3 GLN B 309 ASN B 316 -1 N GLN B 309 O GLU B 325 SHEET 1 I 2 ASN B 369 HIS B 374 0 SHEET 2 I 2 ARG B 380 THR B 385 -1 O VAL B 381 N ALA B 373 SHEET 1 J 3 LEU B 443 ILE B 447 0 SHEET 2 J 3 ALA B 450 ILE B 454 -1 O ILE B 454 N LEU B 443 SHEET 3 J 3 TYR B 561 SER B 563 1 O HIS B 562 N CYS B 451
SITE 1 AC1 14 LEU A 419 ARG A 422 MET A 423 LEU A 474 SITE 2 AC1 14 HIS A 475 SER A 476 TYR A 477 ILE A 482 SITE 3 AC1 14 ALA A 486 TRP A 528 VAL A 530 LYS A 533 SITE 4 AC1 14 HOH A 731 HOH A 806 SITE 1 AC2 11 LEU B 419 ARG B 422 MET B 423 LEU B 474 SITE 2 AC2 11 HIS B 475 SER B 476 TYR B 477 ILE B 482 SITE 3 AC2 11 ALA B 486 TRP B 528 LYS B 533
CRYST1 85.420 105.369 126.431 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.011707 0.000000 0.000000 0.00000
SCALE2 0.000000 0.009490 0.000000 0.00000
SCALE3 0.000000 0.000000 0.007909 0.00000